Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

International Journal of Laboratory Hematology, EarlyView.
Source: Clinical and Laboratory Haematology - Category: Hematology Source Type: research